BCAX
Price
$18.17
Change
+$1.02 (+5.95%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
949.37M
Intraday BUY SELL Signals
KURA
Price
$11.96
Change
+$0.83 (+7.46%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
995.48M
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs KURA

Header iconBCAX vs KURA Comparison
Open Charts BCAX vs KURABanner chart's image
Bicara Therapeutics
Price$18.17
Change+$1.02 (+5.95%)
Volume$7.05K
Capitalization949.37M
Kura Oncology
Price$11.96
Change+$0.83 (+7.46%)
Volume$29.18K
Capitalization995.48M
BCAX vs KURA Comparison Chart in %
BCAX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCAX vs. KURA commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a StrongBuy and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BCAX: $17.16 vs. KURA: $11.15)
Brand notoriety: BCAX and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 24% vs. KURA: 34%
Market capitalization -- BCAX: $949.37M vs. KURA: $995.48M
BCAX [@Biotechnology] is valued at $949.37M. KURA’s [@Biotechnology] market capitalization is $995.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, BCAX is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 5 TA indicator(s) are bullish while KURA’s TA Score has 4 bullish TA indicator(s).

  • BCAX’s TA Score: 5 bullish, 5 bearish.
  • KURA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KURA is a better buy in the short-term than BCAX.

Price Growth

BCAX (@Biotechnology) experienced а -7.04% price change this week, while KURA (@Biotechnology) price change was -3.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($995M) and BCAX($949M) have the same market capitalization . KURA YTD gains are higher at: 28.014 vs. BCAX (-1.493). BCAX has higher annual earnings (EBITDA): -121M vs. KURA (-192.46M). KURA has more cash in the bank: 631M vs. BCAX (437M). BCAX has less debt than KURA: BCAX (2.24M) vs KURA (19.5M). KURA has higher revenues than BCAX: KURA (83.3M) vs BCAX (0).
BCAXKURABCAX / KURA
Capitalization949M995M95%
EBITDA-121M-192.46M63%
Gain YTD-1.49328.014-5%
P/E Ratio3.22N/A-
Revenue083.3M-
Total Cash437M631M69%
Total Debt2.24M19.5M11%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXKURA
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
85%
Momentum
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
70%
MACD
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGIRX101.14N/A
N/A
JPMorgan U.S. GARP Equity R5
VSCAX26.69N/A
N/A
Invesco Small Cap Value A
MPAIX28.00N/A
N/A
Morgan Stanley Inst Advantage I
LGOVX36.59N/A
N/A
Lord Abbett Growth Opportunities R6
ISGNX17.58N/A
N/A
Columbia Integrated Small Cap Gr Instl

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with KURA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-0.98%
KURA - BCAX
42%
Loosely correlated
-2.53%
IMNM - BCAX
41%
Loosely correlated
-6.71%
SYRE - BCAX
41%
Loosely correlated
-0.91%
BMRN - BCAX
39%
Loosely correlated
-2.07%
ORKA - BCAX
39%
Loosely correlated
+0.56%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-2.53%
XNCR - KURA
58%
Loosely correlated
-3.15%
CLDX - KURA
53%
Loosely correlated
+2.85%
RGNX - KURA
53%
Loosely correlated
-3.10%
IMTX - KURA
51%
Loosely correlated
-3.70%
DYN - KURA
48%
Loosely correlated
-2.96%
More